500 related articles for article (PubMed ID: 36809426)
41. Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities.
Hirmas N; Hamacher R; Sraieb M; Ingenwerth M; Kessler L; Pabst KM; Barbato F; Lueckerath K; Kasper S; Nader M; Schildhaus HU; Kesch C; von Tresckow B; Hanoun C; Hautzel H; Aigner C; Glas M; Stuschke M; Kümmel S; Harter P; Lugnier C; Uhl W; Niedergethmann M; Hadaschik B; Grünwald V; Siveke JT; Herrmann K; Fendler WP
J Nucl Med; 2023 May; 64(5):711-716. PubMed ID: 36581374
[TBL] [Abstract][Full Text] [Related]
42.
Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
[TBL] [Abstract][Full Text] [Related]
43. Role of [
Zhao L; Pang Y; Luo Z; Fu K; Yang T; Zhao L; Sun L; Wu H; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1944-1955. PubMed ID: 33415432
[TBL] [Abstract][Full Text] [Related]
44. [
Zheng J; Liu F; Lin K; Zhang L; Huang N; Zheng W; Zhang J; Yao S; Miao W
Mol Imaging Biol; 2022 Dec; 24(6):973-985. PubMed ID: 35945360
[TBL] [Abstract][Full Text] [Related]
45. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
[TBL] [Abstract][Full Text] [Related]
46. One-stop [
Liu G; Mao W; Yu H; Hu Y; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2271-2281. PubMed ID: 36971806
[TBL] [Abstract][Full Text] [Related]
47. Higher accuracy of [
Zhou X; Wang S; Xu X; Meng X; Zhang H; Zhang A; Song Y; Zhu H; Yang Z; Li N
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2983-2993. PubMed ID: 35543731
[TBL] [Abstract][Full Text] [Related]
48. Usefulness of [
Chen H; Zhao L; Ruan D; Pang Y; Hao B; Dai Y; Wu X; Guo W; Fan C; Wu J; Huang W; Lin Q; Sun L; Wu H
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):73-86. PubMed ID: 32588089
[TBL] [Abstract][Full Text] [Related]
49. A head-to-head comparison of
Qin C; Liu F; Huang J; Ruan W; Liu Q; Gai Y; Hu F; Jiang D; Hu Y; Yang K; Lan X
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3228-3237. PubMed ID: 33609152
[TBL] [Abstract][Full Text] [Related]
50.
Luo Y; Pan Q; Zhou Z; Li M; Wei Y; Jiang X; Yang H; Li F
Radiology; 2023 May; 307(3):e222052. PubMed ID: 36853178
[TBL] [Abstract][Full Text] [Related]
51. [
Wu C; Zhang X; Zeng Y; Wu R; Ding L; Xia Y; Chen Z; Zhang X; Wang X
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):194-204. PubMed ID: 36040490
[TBL] [Abstract][Full Text] [Related]
52. Clinical Evaluation of
Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H
J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301
[TBL] [Abstract][Full Text] [Related]
53.
Sahin E; Kus T; Aytekin A; Uzun E; Elboga U; Yilmaz L; Cayirli YB; Okuyan M; Cimen V; Cimen U
J Nucl Med; 2024 Apr; 65(4):512-519. PubMed ID: 38485276
[TBL] [Abstract][Full Text] [Related]
54. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
[TBL] [Abstract][Full Text] [Related]
55. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
[TBL] [Abstract][Full Text] [Related]
56.
Li C; Chen Q; Tian Y; Chen J; Xu K; Xiao Z; Zhong J; Wu J; Wen B; He Y
J Nucl Med; 2024 Apr; 65(4):527-532. PubMed ID: 38453362
[TBL] [Abstract][Full Text] [Related]
57. Dual targeting PET tracer [
Wang R; Jakobsson V; Wang J; Zhao T; Peng X; Li B; Xue J; Liang N; Zhu Z; Chen X; Zhang J
Theranostics; 2023; 13(9):2979-2992. PubMed ID: 37284441
[No Abstract] [Full Text] [Related]
58. Comparison of 68 Ga-FAPI-04 PET/CT with 18 F-FDG PET/CT for diagnosis and staging of gastric and colorectal cancer.
Wang B; Zhao X; Liu Y; Zhang Z; Chen X; Jing F; Chen X; Hua Y; Zhao J
Nucl Med Commun; 2024 Jul; 45(7):612-621. PubMed ID: 38686487
[TBL] [Abstract][Full Text] [Related]
59. Head-to-Head Comparison of
Promteangtrong C; Siripongsatian D; Jantarato A; Kunawudhi A; Kiatkittikul P; Yaset S; Boonkawin N; Chotipanich C
J Nucl Med; 2022 Aug; 63(8):1155-1161. PubMed ID: 34857655
[No Abstract] [Full Text] [Related]
60. Comparison of Baseline
Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
